BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3341657)

  • 1. Stopping antibiotic therapy in neutropenic patients.
    DiNubile MJ
    Ann Intern Med; 1988 Feb; 108(2):289-92. PubMed ID: 3341657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combating infections in neutropenic patients.
    Pizzo PA
    Hosp Pract (Off Ed); 1989 Jul; 24(7):93-100, 103-4, 107-10. PubMed ID: 2501330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superinfections during antimicrobial treatment with betalactam-aminoglycoside combinations in neutropenic patients with hematologic malignancies.
    Serra P; Santini C; Venditti M; Mandelli F; Martino P
    Infection; 1985; 13 Suppl 1():S115-22. PubMed ID: 4055041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of the febrile neutropenic patient.
    Mandell LA
    Can Med Assoc J; 1983 Apr; 128(8):915-7. PubMed ID: 6831337
    [No Abstract]   [Full Text] [Related]  

  • 5. Empirical antimicrobial therapy in the neutropenic host.
    Young LS
    N Engl J Med; 1986 Aug; 315(9):580-1. PubMed ID: 3526156
    [No Abstract]   [Full Text] [Related]  

  • 6. Low morbidity and mortality from infection in neutropenic patients, a possible result of multiple measures of infection prevention.
    Grob JP; Francioli P; Pécoud A; Glauser MP
    Schweiz Med Wochenschr Suppl; 1983; 14():70-5. PubMed ID: 6581532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stopping antibiotics in neutropenic patients.
    Cheesbrough JS; Murray A
    Ann Intern Med; 1988 Jun; 108(6):908. PubMed ID: 3369786
    [No Abstract]   [Full Text] [Related]  

  • 8. Antimicrobial prophylaxis against infection in neutropenic patients.
    Young LS
    J Infect Dis; 1983 Apr; 147(4):611-4. PubMed ID: 6842001
    [No Abstract]   [Full Text] [Related]  

  • 9. The febrile neutropenic patient: newer options for empirical therapy.
    Rubin M; Walsh T; Butler K; Lee J; Lecciones J; Weinberger M; Roilides E; Gress J; Marshall D; Pizzo PA
    Haematol Blood Transfus; 1990; 33():531-8. PubMed ID: 2157645
    [No Abstract]   [Full Text] [Related]  

  • 10. The results of a randomized trial of empirical antibiotic treatment in febrile neutropenic patients with four beta-lactam/aminoglycoside combinations.
    Hann I; Noone P; Prentice HG; Sage R; Blacklock H; Stirling L; Gray R; Corringham R; Boesen E; Mohiuddin J
    J Antimicrob Chemother; 1983 May; 11 Suppl C():57-63. PubMed ID: 6352605
    [No Abstract]   [Full Text] [Related]  

  • 11. Current issues in the antibiotic primary management of the febrile neutropenic cancer patient: a perspective from the National Cancer Institute.
    Pizzo PA
    J Hosp Infect; 1990 Apr; 15 Suppl A():41-8. PubMed ID: 1971644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Empiric treatment of infections in neutropenic patients with cancer.
    Klastersky J
    Rev Infect Dis; 1983; 5 Suppl 1():S21-31. PubMed ID: 6342096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Application of the concepts of evidence-based medicine to the evidence on the treatment of febrile neutropenia].
    Jarque I; Sanz MA
    Enferm Infecc Microbiol Clin; 1999; 17 Suppl 2():95-102. PubMed ID: 10605194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic broad-spectrum antimicrobial prophylaxis in hematological patients after intensive antineoplastic chemotherapy.
    Verlicchi F; Ricci P; Bassi A; Benfenati D; Bandini G; Rosti G; Calori E; Borghi C; Tura S
    Haematologica; 1990; 75(1):91-3. PubMed ID: 2338294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever.
    Hughes WT; Armstrong D; Bodey GP; Feld R; Mandell GL; Meyers JD; Pizzo PA; Schimpff SC; Shenep JL; Wade JC
    J Infect Dis; 1990 Mar; 161(3):381-96. PubMed ID: 2179420
    [No Abstract]   [Full Text] [Related]  

  • 16. Evolution of antibiotic therapy for infection in neutropenic patients: studies at M. D. Anderson Hospital.
    Bodey GP
    Rev Infect Dis; 1989; 11 Suppl 7():S1582-90. PubMed ID: 2690296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylaxis of bacterial infections with oral antibiotics in neutropenic patients. Lessons from the last two EORTC trials and prospects for the future.
    Zinner SH
    Schweiz Med Wochenschr Suppl; 1983; 14():7-14. PubMed ID: 6361995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic therapy for the febrile granulocytopenic cancer patient: combination therapy vs. monotherapy.
    Wade JC
    Rev Infect Dis; 1989; 11 Suppl 7():S1572-81. PubMed ID: 2690295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fever in the neutropenic patient].
    Milpied N
    Rev Prat; 2001 Mar; 51(6):633-7. PubMed ID: 11345865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy of choice for the empiric treatment of the febrile neutropenic patient.
    Barriere SL
    Drug Intell Clin Pharm; 1986 Oct; 20(10):767-9. PubMed ID: 3769764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.